Evaluation of Marginal Bone Loss (MBL) 12 Months Post-loading of Implants Supporting Individual Crowns, Based on the Height of the Intermediate Abutment and Its Placement Time. Immediate Abutments of 2 or 3 Mm Show the Lowest MBL, Whereas 1.5 Mm or Delayed Abutments Are Associated with Higher MBL.

October 29, 2024 updated by: Jacobo Quintas Hijós, Quintas Hijós Clínica Dental

Influence of Intermediate Abutment Height and Timing of Placement on Peri-implant Marginal Bone Loss in Single Implant-supported Crowns: a 12-month Follow-up Randomized Clinical Trial.

Objectives:To determine which combination of abutment height and timing of placement is most effective in reducing marginal bone loss (MBL).

Materials and Methods: 54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery1), group 2 (height 2; surgery1), group 3 (height 1.5; surgery1), group 4 (height 3; surgery2), group 5 (height 2; surgery2), group 6 (height 1.5; surgery2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant surgery, crown placement (T1), and at 3 (T2), 6 (T3), and 12 months after loading (T4). Partial and total MBL were compared among the treatment groups.

Study Overview

Detailed Description

All installed implants were BTI UnicCa® implants with a flat tetragonal internal connection (BTI Implant System, Vitoria, Spain) of universal (4.1 mm) or wide (5.5 mm) diameter. On all implants, anti-rotational intermediate abutments Ti Golden® UNIT (BTI Implant System, Vitoria, Spain) of universal (4.1 mm) or wide (5.5 mm) width and 1.5 mm, 2.0 mm, or 3.0 mm height were connected, either immediately during the installation surgery (protocol in one phase: one abutment - one time) or delayed during the second surgery procedure 8 weeks after installation (protocol in two phases: submerged implant). (Figure 1). For all patients, standardized digital intraoral radiographs with a silicone key and Rhin ring positioner were recorded during the surgical installation of the implant (baseline), during the placement of the prosthetic crown (8 weeks after surgery), and at 3, 6, and 12 months after prosthetic loading.

  • Surgical Procedures. Patients received a complete clinical (periodontal chart) and radiographic (intraoral radiographs, orthopantomography, and CBCT) examination. All surgical procedures were performed by the same surgeon (JQH) under local anesthesia (Artinibsa®; Inibsa Dental SLU, Barcelona, Spain). The implant size was selected based on digital planning with CBCT (Planmeca Romexis Software) according to the quantity and quality of bone. Prior to surgery, the thickness of the soft tissue (from the mucosal surface to the crestal bone) at the implant placement site was measured with a periodontal probe (15 mm, PCP UNC 15; HuFriedy). A conventional placement protocol was followed, with delayed installation of the implant in a fully healed socket (minimum 16 weeks of healing after tooth extraction). Osteotomy was performed without irrigation at low revolutions (100 rpm) following the defined protocol according to implant size and bone density. All implants were placed 1.5 mm subcrestally. All patients received pharmacological prescription with antibiotics (Amoxicillin 1 g every 12 hours for 7 days) or clindamycin in case of allergy, anti-inflammatory medication (Dexketoprofen 25 mg every 8 hours for 3 days), and probiotics (1 sachet per day for 1 week), in addition to postoperative care instructions: pressure with gauze for 5 minutes, application of ice for 10 minutes, soft and cold diet for the first 24 hours, and rinses with 0.12% chlorhexidine (Perioaid; Dentaid SL; Cerdanyola, Spain) twice a day for 7 days. Sutures were removed after 7 days.
  • Restorative Procedures. Eight weeks after the implant installation surgery, the platforms of the submerged implants were exposed and the intermediate abutment was connected with a torque of 35 Ncm. Ten weeks after surgery and after increasing the intermediate abutment torque to 35 Ncm on the non-submerged implants, the prosthetic phase began for all cases. All definitive implant-supported prostheses were unitary screw-retained metal-ceramic crowns. Records for the laboratory were obtained in all cases through digital intraoral scanning (iTero®; Align Technology Inc; San José; California, USA). The CAD design of the restorations was done using Exocad Software. The CAM fabrication of the restorations involved milling the metal framework and layering the ceramic covering on a printed model. The unitary crowns were screwed in 2 weeks after the scanning phase with a prosthetic screw torque of 20 Ncm (conventional loading for all cases: 12 weeks after implant placement surgery). The screw channels were sealed with Teflon and compact composite (GrandioSo; Voco GmbH; Cuxhaven, Germany). Occlusion was adjusted, and the adequacy of contact points and gingival sealing was checked.
  • Radiographic Evaluation. Standardized digital intraoral radiographs with a silicone key and Rhin ring positioner (Planmeca Prox + Planmeca Prosensor HD; Planmeca Oy; Helsinki, Finland) were obtained at implant placement (baseline), at definitive crown placement (T1), and at 3 months (T2), 6 months (T3), and 12 months (T4) after functional loading. For MBL measurement, the Planmeca Romexis dental imaging software platform was used. Linear measurements were taken in each intraoral radiograph from the most mesial and distal point of the implant shoulder to the crestal bone. The magnification of the radiographs was corrected based on the radiographic measurement of the height and width of each implant, from which each linear MBL measurement was calibrated and recalculated.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Salamanca, Spain, 37008
        • University of Salamanca

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults.
  • Plaque and bleeding indices below 10%.
  • Absence of chronic periodontal diseases (periodontitis) or acute periodontal diseases (periodontal abscess).
  • Presence of intact alveolar walls.
  • Sufficient bone height and width.
  • Need for restoration of a tooth in the posterior maxillary or mandibular region (premolars and molars).
  • Incorporation into a periodontal maintenance program.

Exclusion Criteria:

  • History of systemic disease or radiotherapy contraindicating bone surgery.
  • Pregnant or breastfeeding women.
  • Smokers of more than 10 cigarettes per day.
  • Parafunctional habits.
  • Alcohol or drug abuse.
  • Narrow interproximal spaces (less than 9 mm).
  • Placement of implants flapless or post-extraction.
  • Insertion torque during implant placement below 35 Ncm.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1 (height 3; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Active Comparator: Group 2 (height 2; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Active Comparator: Group 3 (height 1.5; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Active Comparator: Group 4 (height 3; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Active Comparator: Group 5 (height 2; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Active Comparator: Group 6 (height 1.5; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Other Names:
  • Oral Surgery
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Other Names:
  • Oral Surgery
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Marginal bone loss (MBL) measured in mm (mm) 12 months after loading the implant.
Time Frame: 12 months
Cumulative MBL after 12 months of prosthetic loading measured in millimeters.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evolution over time of marginal bone loss (MBL) measured in millimeters (mm) at different stages.
Time Frame: 0, 3, 6, 12 months.
Partial MBL on the day of crown placement and 3, 6 and 12 months after loading, measured in millimeters.
0, 3, 6, 12 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Esteban Pérez Pevida, Dentistry, University of Salamanca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2022

Primary Completion (Actual)

May 1, 2024

Study Completion (Actual)

June 28, 2024

Study Registration Dates

First Submitted

October 27, 2024

First Submitted That Met QC Criteria

October 29, 2024

First Posted (Actual)

October 31, 2024

Study Record Updates

Last Update Posted (Actual)

October 31, 2024

Last Update Submitted That Met QC Criteria

October 29, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Marginal Bone Loss

Clinical Trials on Implant

Subscribe